Neurohumoral Modulators in Heart Failure, An Issue of Heart Failure Clinics
By Gregg Fonarow, MD
240 pages,
Copyright 2005
ISBN:1416026649
Contents
1. Neurohormonal Upregulation in Heart Failure (Francis) 2. Neurohumoral Substrate in the Community and in Populations Susceptible to Heart Failure (Ramachandran) 3. Role and Optimal Dosing of ACE Inhibitor Therapy (Deswal) 4. Could Beta-Blockers Precede or Replace ACE-Inhibitors in Heart Failure? (Remme) 5. Relevance of Aldosterone Antagonists: Is There a Need to Readjust Angiotensin Inhibition? (Pitt) 6. Novel Neurohumoral Antagonists (Udelson) 7. Natriuretic Peptides and Remodeling in Heart Failure (Burnett) 8. Pharmacogenomics for Neurohormonal Intervention in Heart Failure (McNamara) 9. Role of Neurohumoral Modulators in Heart Failure with Preserved Systolic Function (Gheorghiade) 10. Neural Endopeptidase Inhibitors and Endothelin Antagonists: Why Did the Clinical Trials Not Demonstrate Beneficial Effects? (Abraham) 11. Should Neurohormonal Intervention Be Recommended in Heart Failure Stage A? (Fonarow) 12. ACE-Inhibitors Only, ARBs Only or Both (Young) 13. Are There Clinically Important Differences Between Beta-Blockers in Heart Failure? (Cleland)